The occurrence of psychosis in association with replacement therapy for hypothyroidism was first reported by Ziegler (1931). At that time, he noted the onset of pressure of speech, psychomotor agitation, clang associations and auditory hallucinations within a few days of the initiation of thyroid replacement therapy in one of his patients. Easson (1966) These findings suggest that a group of hypothyroid patients at risk can be identified. In such a group, lower initial dosages and gradual increases in dosage may be indicated.
shed light on the elusive, but ineluctable relationship between thyroid activity and affective disturbance. Second, delineation of patients at risk would permit increased atten tion to their post-treatment course. This might result in earlier recognition and control of severe psychopathological disturbance.
This report, based on our literature review, outlines the characteristic features of this syndrome. Our discussion considers the theo retical underpinnings of the phenomenon and possible clinical application.
Method
A retrospective review of the English language literature describing psychotic reactions asso ciated with thyroid administration was undertaken. To aid this review, a Medlars computer search was used with these code words:
â€˜¿ hypothyroid', â€˜¿ treatment', and â€˜¿ psychosis'.
Case reports with supporting clinical data were then reviewed with respect to the variables enumerated in Tables I and IV. A , 1978) . Dosages in early reports must be considered approximations because of variability in potency of available preparations.
Results
The literature is replete with references to psychosis following thyroid supplementation in hypothyroidism. For example, Jellinek (1962) has reported on 56 hypothyroid patients with concomitant neurological disorder, 18 of whom had psychiatric disorder. Some of these psych iatric disorders occurred with the initiation of treatment. We found 25 specific cases of this phenomenon but in only 18 were clinical data sufficient for analysis. Table I lists these cases by reporting author.
The characteristic clinical picture of the PFI included the presence of psychopathology prior to the initiation of therapy, the appearance or exacerbation of psychotic symptoms within 4â€"7days of treatment initiation and resolution in 1â€"2weeks irrespective of therapeutic inter vention. The diagnosis of organic affective syndrome, manic type, most often applied to the PFI episodes. The average age at onset was 47 years, the female to male sex ratio was 17 to 1, and the average initial adult dosage was 180 micrograms sodium levo-thyroxine (exclud ing two cases oflife-threatening hypothyroidism). The average duration of hypothyroidism was 28 months, the majority occurring spon taneously. The PFI, though transient, resulted in psychiatric intervention in over half of the cases. These interventions ranged from psych iatric consultation and initiation of neuroleptic medication to the immediate application of restraints and transfer to a psychiatric hospital. All cases, even those not receiving psychiatric intervention, were judged to be severely impaired at the time of the PFI. Complete recovery from PFI occurred in all cases. Resolution of the PFI took place sooner than recovery from medical and psychiatric distur bance evident prior to the treatment.
Many of these reports did not include systematic mental state examinations. Further, psychiatric personnel were not always present during the psychosis. Consequently, certain symptoms may be underestimated.
With this limitation, the frequency of symptomatology reported during the PFI is recorded in Table II . Increased psychomotor activity, persecutory delusions and elevated or irritable mood were the most frequent manifestations. Several cate gories need further delineation. The behaviour noted in patients with poor judgement included engaging in assaultive behaviour toward medical staff (7 occurrences), attempting to leave the hospital (2 occurrences) and attempting to correct thyroid deficiency by ingesting a container of pills (1 occurrence). The depressed patients included three with suicidal ideation, two of whom made attempts.
These attempts were judged to be potentially lethal. The first patient tried to jump out a window. The second attempted to ingest buttons, smelling salts, a comb and bed sheets and, when re strained, tried to suffocate herself. Those patients with anxiety experienced considerable distress best described as panic with a sense of impending danger. Comment on the quality of sleep was frequently omitted. In the case observed by ourselves, however, insomnia was a prominent feature.
The DSMâ€"III diagnoses assigned are listed in Table III . The use of the word organic in dicates that a specific organic factor was judged to be aetiologically related to the disturbance. It is not meant to imply that disturbances in memory, orientation or attention were promi nent. 
Discussion
Our survey indicates that when thyroid replacement is complicated by the emergence of psychosis, a characteristic clinical picture un folds. The syndrome, referred to as the PFI, appears 4-7 days after aggressive initiation of thyroid replacement, the average initial daily dosage being greater than 150 micrograms of thyroxine.The psychosislasts one to two weeks and resolves without sequelae, irrespective of therapeutic intervention.
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This syndrome appears to be distinct from the mental changes associated with hypothy.. roidism. First, the peak of psychopathologic disturbance is coincident with the occurrence of peak activity after thyroxine administration (Astwood, 1975) . The time course of recovery, one to two weeks, is distinct from the gradual resolution of mental sequelae secondary to hypothyroidism. Second, the psychopathological features meet DSMâ€"III criteria for an organic affective syndrome, manic type. Increased psychomotor activity, persecutory delusions, elation and irritability are particularly pro minent. This homogeneity is in contrast with the protean manifestations of the psychosis associated with hypothyroidism (Olivarius and Roder, 1970) .
This syndrome appears to be uncommon. While hypothyroidism has a prevalence of 1 per cent, we could locate only 25 cases of PFI in the literature. This frequency, however, may be spuriously low due to underreporting of the phenomenon. The psychopathology follow ing initiation, usually unobserved by psychiatric personnel, may be dismissed as a continuation of mental dysfunction secondary to hypo thyroidism. Alternatively, it may be viewed as an unrelated mental disorder or a variant of the common side effects of headache, palpitations and anxiety (Refetoff, 1975) . Irrespective of its incidence, the syndrome carries a considerable risk of morbidity. Attempted ingestion, self mutilation, externally directed aggression and elopement aredocumented complications. The excellent prognosis associated with PFI empha sizes the need to protect these patients during the period of their psychosis.
The preponderance of manic symptomatology is consistent with the role thyroid hormone is known to play in modulating catechol receptor sensitivity (Prange, 1969) . Animal research has demonstrated a decreased receptor sensitivity to CNS catecholamines in hypothyroidism accompanied by a compensatory increase in catechol concentration (K.lawans et al, 1974; Stolk and Whybrow, 1975) . In the presence of increased catechol concentrations, rapid ad ministration of thyroxine could abruptly aug ment catechol receptor sensitivity, thereby precipitating a hypercatecholaminergic state.
Such a state is thought to be the neurochemical basis for mania (Akiskal and McKinney, 1975) . This hypothesis is consistent with Bunney's speculation that the switch process is mediated by alterations in receptor site sensitivity (Bunney ci al, 1972) . In order to elucidate the role of pathological fluctuations in thyroid activity in the onset of mania, Checkley (1978) reviewed the course of 267 patients with a history of affective disorder. Five of these patients had well documented episodes of thyrotoxicosis. He found no correlation between the onset of excessive thyroid activity and the appearance of mania. However, in Checkley's series, the hyperthyroid state developed gradu ally in euthyroid patients. In contrast our patients were shifted from a chronic hypothyroid state to a fully replaced state in several days. We speculate that it is rapidity of change in thyroid activity relative to neurotransmitter receptor balance which is important in the switch process rather than the absolute level of thyroid activity.
Concurrent psychosis appears to be the most useful predictor of the occurrence of a PFI. In only two of his 30 subjects were psychotic symptoms obser ved secondary to hypothyroidismâ€"one subject was paranoid, the other experiencing hallu cinations. The rarity of psychosis in his series agrees with recent observations of hypothyroid patients (Lidz, 1971) . In view of this low incidence, the high frequency of pre-treatment psychosis in our patients supports its usefulness as a predictor. Women, and persons with a personal or family history of mental disorder, appear to be at increased risk for PFI. Over 90 per cent of our patients were female. This striking predomin ance may reflect an interaction between the increased incidence of affective disorder (2: 1) and thyroid disease (4:1) in women. Our data point to a relatively high incidence of personal or family psychiatric history in persons who develop the PFI. In those case reports which provided sufficient data, 50 per cent of subjects gave a positive history of mental disorder in themselves or first degree relatives. Investi gatipn of these aspects of the medical history prior to initiation of treatment would seem indicated.
The ratio of spontaneous to induced in our sample is not sufficiently different from the ratio of their overall incidence to support aetiology as a risk factor. However, the fact that in 81 per cent of our patients, the duration of hypothyroidism was greater than six months, suggests that duration of the preceding hypo thyroid state may be related to the risk of PFI, irrespective of aetiology.
Lidz (1971) has suggested a lower initial replacement dosage be given to hypothyroid patients who are psychiatrically disturbed. Our data support this strategy. In 80 per cent of our subjects, replacement therapy was initiated with a maintenance dosage of at least 150 micrograms of thyroxine. Use of a lower dose has a prece dent in cardiac patients where aggressive introduction of therapy can precipitate angina pectoris. This can be avoided or mitigated with a reduced initial dose. Could the PFI have been averted with a lower initial dosage and slower incremental adjustments? A case report of a young hypothyroid woman addresses this question (Means, 1948) . Means noted the onset of mania seven days after the initiation of thyroid replacement which cleared after the cessation of treatment. The psychosis recurred when thyroid was re-initiated and again remitted after discontinuation of therapy. The third attempt at treatment, begun at 20 per cent of the previous initial dosage, resulted in an uneventful course of therapy. We believe that individuals who fit the high risk profile, namely middle-aged women with psychotic symptoms who have a positive personal or family psych iatric history, should be. given a lower initial dosage and closely observed for the onset of mania early in the course of their treatment.
Our conclusions must be tempered by the acknowledgement that retrospective studies have significantlimitations (Kerlinger, 1973 
